Unique Position NeoKare is the only 100% human milk derived company in the UK and Europe, creating a strong competitive moat for neonatal nutrition buyers. Target institutions include NHS NICUs, private maternity hospitals, and regional neonatology centers that prioritize human milk-based solutions. Propose pilot programs and long-term supply agreements leveraging excess donor milk from UK mothers.

Hospital Partnerships Primary sales path is through direct hospital contracts, milk bank collaborations, and regional procurement schemes. Build partnerships with milk banks and hospital nutrition committees to ensure steady supply of human-milk-derived nutrition for premature infants, with clear pricing, regulatory compliance, and product specifications. Offer flexible contract terms and volume-based incentives to accelerate adoption.

Product Expansion Opportunity to broaden product portfolio with fortifiers, specialized formulas for varying gestational ages, and co-branded innovations. Explore white-label opportunities with distributors or healthcare brands to accelerate market reach while maintaining ethical sourcing and traceability.

Digital Education Leverage current tech stack to enable B2B procurement and education. Develop clinician-focused marketing: case studies, white papers, and clinical outcomes to build credibility; optimize online procurement portals and inventory management for hospitals; invest in regulatory messaging and GMP compliance to reassure buyers.

Scale Partnerships Operational scale requires scalable partnerships and possibly external capital. Pursue distribution agreements with European medical suppliers, advocacy with NHS procurement, and selective international expansion (e.g., North America through partnerships with milk banks or similar operations) to grow revenue beyond current 0-1M range.